UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Virtual Clinician Research Tool

Not Applicable

Completed

Conditions: Elevated Risk of Cardiovascular Disease
Tobacco Dependence

Interventions: Other: No VCRT, only physician counseling at visits
Other: Virtual Clinician Research Tool (VCRT)

First Posted Date: 2011-08-03

Last Posted Date: 2017-02-28

Lead Sponsor: University of Rochester

Target Recruit Count: 79

Registration Number: NCT01408758

Locations: 🇺🇸
University of Rochester Medical Center Healthy Living Center, Rochester, New York, United States

Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1

Phase 2

Completed

Conditions: Myotonic Dystrophy

Interventions: Drug: Placebo
Drug: Mexiletine

First Posted Date: 2011-08-01

Last Posted Date: 2018-06-19

Lead Sponsor: University of Rochester

Target Recruit Count: 42

Registration Number: NCT01406873

Locations: 🇺🇸
University of Rochester Medical Center, Department of Neurology, Rochester, New York, United States

Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis

Phase 2

Completed

Conditions: Juvenile Neuronal Ceroid Lipofuscinosis

Interventions: Drug: Liquid Placebo
Drug: Mycophenolate mofetil

First Posted Date: 2011-07-21

Last Posted Date: 2019-05-21

Lead Sponsor: University of Rochester

Target Recruit Count: 19

Registration Number: NCT01399047

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Objective Evaluation of Ocular Surface Lubricants in Two Environments

Early Phase 1

Completed

Conditions: Dry Eye

Interventions: Drug: B & L Soothe Lubricant Eye Drops
Drug: Liposic EDO
Drug: OcuFresh Eye Wash

First Posted Date: 2011-06-17

Last Posted Date: 2022-11-22

Lead Sponsor: University of Rochester

Target Recruit Count: 20

Registration Number: NCT01375582

Locations: 🇺🇸
Flaum Eye Institute at the University of Rochester, Rochester, New York, United States

Oral Ketamine for Control of Chronic Pain in Children

Phase 1

Completed

Conditions: Chronic Pain

Interventions: Drug: Ketamine

First Posted Date: 2011-06-09

Last Posted Date: 2013-02-15

Lead Sponsor: University of Rochester

Target Recruit Count: 12

Registration Number: NCT01369680

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

eMOMS of Rochester

Phase 3

Completed

Conditions: Gestational Weight Gain
Postpartum Weight Retention

Interventions: Behavioral: Control
Behavioral: electronic intervention during pregnancy and postpartum
Behavioral: electronic intervention during pregnancy

First Posted Date: 2011-04-08

Last Posted Date: 2015-12-02

Lead Sponsor: University of Rochester

Target Recruit Count: 1641

Registration Number: NCT01331564

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Study Of Telemedicine Consultation at Home For Older Adults

Completed

Conditions: Telemedicine
Physical Disorders

Interventions: Other: Telemedicine care

First Posted Date: 2011-03-29

Last Posted Date: 2017-06-09

Lead Sponsor: University of Rochester

Target Recruit Count: 1537

Registration Number: NCT01324687

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Imexon for Relapsed Follicular and Aggressive Lymphomas

Phase 2

Completed

Conditions: Small Lymphocytic Lymphoma
Marginal Zone Lymphoma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Lymphoplasmacytic Lymphoma
Burkitt's Lymphoma

Interventions: Drug: Imexon

First Posted Date: 2011-03-14

Last Posted Date: 2016-01-06

Lead Sponsor: University of Rochester

Target Recruit Count: 22

Registration Number: NCT01314014

Locations: 🇺🇸
Arizona Cancer Center, University of Arizona, Tucson, Arizona, United States
🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Forensic Assertive Community Treatment: An Emerging Model of Service Delivery

Phase 3

Completed

Conditions: Psychotic Disorders

Interventions: Behavioral: Enhanced Treatment as Usual
Behavioral: Forensic Assertive Community Treatment (FACT)

First Posted Date: 2011-03-11

Last Posted Date: 2017-02-28

Lead Sponsor: University of Rochester

Target Recruit Count: 53

Registration Number: NCT01313052

Locations: 🇺🇸
Monroe County Jail, Rochester, New York, United States

Monitoring Minimal Residual Disease of Patients with Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

Recruiting

Conditions: Myelodysplastic Syndrome
Acute Myeloid Leukemia

First Posted Date: 2011-03-09

Last Posted Date: 2024-10-11

Lead Sponsor: University of Rochester

Target Recruit Count: 400

Registration Number: NCT01311258

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy